KJ was born last year with a genetic disorder called carbamoyl-phosphate synthetase 1 deficiency. When he was 6 months old, doctors began giving KJ a groundbreaking new treatment — a personalized CRISPR gene editing therapy at Children’s Hospital of Philadelphia. Read More.
